BRISBANE, Australia and EAGAN, Minn., March 02, 2022 (GLOBE NEWSWIRE) — Anteris Technologies Ltd (Anteris or the Company) Limited (ASX: AVR) announces the Company has entered a binding agreement to place 1,840,000 new Ordinary Shares (New Shares) raising USD 20 million ($A 28 million) to Perceptive Life Sciences Master Fund, […]
Author: Ken Dropiewski
HeartBeam Partners with Phoebe Putney Health System for First Pilot Study of Emergency Department Myocardial Infarction Software
Business Associate Agreement and Clinical Trial Agreement with Additional Planned Studies and Commercial and Scientific Collaboration SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today announced it has signed a Business Associate Agreement (BAA) and Clinical […]
Cardior Appoints Cardiac Disease and RNA Drug Development Experts to its Scientific Advisory Board Supporting Pipeline Expansion in Both Large and Orphan Cardiac Indications
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the expansion of its Scientific Advisory Board (SAB) with four newly appointed cardiology and RNA drug development experts. Johann Bauersachs, MD; Perry Elliott, MD; Gerasimos Filippatos, MD, PhD; and Barry […]
Rapid Medical Announces Eitan Havis as International President
Mr. Havis will Lead Commercialization from Europe to Asia YOKNEAM, Israel & MIAMI–(BUSINESS WIRE)–Rapid Medical, a leading developer of neurovascular devices, announces the promotion of Eitan Havis to President, International. Mr. Havis will oversee the commercial expansion of the company’s advanced neurovascular technologies to treat hemorrhagic and ischemic stroke patients in Europe, […]
Avinger Announces Successful Completion of First Cases with the Lightbox 3 Next Generation Imaging Console
REDWOOD CITY, CA / ACCESSWIRE / February 28, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that physicians in the U.S. have successfully completed first cases with its new […]
HeartFlow Announces CEO Transition
John Farquhar Appointed CEO, John Stevens to Become Vice Chair, Board of Directors MOUNTAIN VIEW, Calif., March 01, 2022 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced that John Farquhar has been appointed President and Chief Executive Officer, effective March 1, 2022. Mr. Farquhar has […]
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results
MINNEAPOLIS, March 01, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the fourth quarter and full year ended December 31, 2021, which included the following highlights: Generated $1.6 million in total revenue for the fourth quarter 2021, 19.6% below the prior-year period and a 20% […]
Clinical Study using QuantaFlo® published in Peer-Reviewed Journal of Vascular Surgery
Results show a positive screening of previously undetected PAD was independently associated with short-term and long-term increased risks for mortality and major adverse cardiovascular events SANTA CLARA, Calif., March 1, 2022 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, […]
Global Health Technology Company CardieX and Mobvoi Launch a Revolutionary Heart Health Monitoring Smartwatch for Consumers
The TicWatch GTH Pro features Arty® Heart Health technology, powered by ATCOR, a subsidiary of CardieX, to monitor arterial and heart health IRVINE, Calif. and SYDNEY, March 1, 2022 /PRNewswire/ — Mobvoi Inc., a leading artificial intelligence-wearable company backed by Google™ and Volkswagen, in partnership with global health tech company CardieX, today announces the launch of […]
Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial
– Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance after stabilization and before discharge compared with placebo – The benefit was consistent in adults with new or existing heart failure and in those with either preserved […]
Recent
Popular
- No commented posts yet